This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

OptumRx Hosts Grand Opening For Jacksonville Customer Service Center

OptumRx, a leading pharmacy benefits management (PBM) organization and one of the Optum companies of UnitedHealth Group (NYSE: UNH), will hold a grand opening ceremony for its newest customer service center Tuesday, Sept. 17, at 9 a.m.

The new customer service center will employ up to 350 Customer Service Representatives (CSR), senior and lead CSRs, customer service supervisors and managers by the end of this year. The center, which operates around the clock, primarily serves Medicare and retiree consumers, handling more than 750,000 calls per month from members nationwide.

U.S. Congressman Ander Crenshaw will join local Jacksonville elected officials and business leaders to mark the grand opening of the OptumRx offices at 7159 Corklan Drive in Jacksonville.

“Jacksonville is a good place to hire great employees and grow our business,” said Mark Knutson, OptumRx senior vice president, Customer Service. “We look forward to increasing our workforce and enhancing our ability to provide a quality health care experience to customers.”

“I am pleased that Optum and UnitedHealth Group recognize Jacksonville’s high-quality workforce and Florida’s excellent business climate,” said Rep. Crenshaw. “The hundreds of jobs Optum has created here show that Florida is a premier destination for the growth of innovative businesses such as Optum. I look forward to a long and successful partnership between Optum and Florida.”

Hiring is ongoing, and people with health care or customer service experience are encouraged to apply online at http://careers.unitedhealthgroup.com/.

OptumRx is currently the third-largest pharmacy benefits manager in the United States, with distinctive expertise and resources, and a proven track record that has led to significant growth. By the end of this year, the company will serve more than 25 million people and process nearly 500 million adjusted retail, mail service and specialty drug prescriptions annually.

About OptumRx

OptumRx is part of Optum, a UnitedHealth Group (NYSE: UNH) company and a leading information and technology-enabled health services business dedicated to making the health system work better for everyone. OptumRx is an innovative pharmacy benefit management business managing the prescription drug benefits of commercial, Medicare, Medicaid and other governmental health plans, as well as those of employers and unions through a national network of 66,000 community pharmacies and state-of-the-art mail service pharmacies in California and Kansas, both of which have earned the prestigious Verified Internet Pharmacy Practice Sites™ (VIPPS) accreditation by the National Association of Boards of Pharmacy. Visit www.optum.com for more information.

About Optum

Optum is a leading information and technology-enabled health services business dedicated to making the health system work better for everyone. Optum is comprised of three companies – OptumHealth, OptumInsight and OptumRx – representing more than 35,000 employees worldwide who collaborate to deliver intelligent solutions that modernize the health system, improve overall population health and support Sustainable Health Communities. Optum serves the broad health care marketplace, including care providers, plan sponsors, government agencies, life sciences companies and consumers.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,132.70 -81.72 -0.45%
S&P 500 2,104.50 -6.24 -0.30%
NASDAQ 4,963.5270 -24.3630 -0.49%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs